These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 31453880)

  • 1. The Influence of Aerosol Density and Shape Factor on the Assessment of Internal Exposure to 239Pu.
    Zhang B; Sheng W; Xu M; Zhang Y; Lei JY; Ma HC
    Health Phys; 2019 Oct; 117(4):353-361. PubMed ID: 31453880
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uncertainties in aerosol deposition within the respiratory tract using the icrp 66 model: a study in workers.
    Fritsch P
    Health Phys; 2006 Feb; 90(2):114-26. PubMed ID: 16404169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AEROSOL SIZE DISTRIBUTION IN URANIUM PROCESSING FACILITY FOR APPLICATION IN THE ASSESSMENT OF INTERNAL EXPOSURE.
    Shailesh M; Das T; Prabhat M; Kolekar RV; Gopalakrishnan RK
    Radiat Prot Dosimetry; 2018 Apr; 179(2):119-124. PubMed ID: 29088460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: regional tissue doses for 239PuO2 and 238UO2/238U3O8.
    Farfán EB; Huston TE; Bolch WE; Vernetson WG; Bolch WE
    Health Phys; 2003 Apr; 84(4):436-50. PubMed ID: 12705442
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Modifying the ICRP 66 dosimetry model based on results obtained from Mayak plutonium workers.
    Romanov SA; Guilmette RA; Hahn FF; Nifatov AP; Zaytseva YV; Lyovkina YV
    Radiat Prot Dosimetry; 2003; 105(1-4):85-90. PubMed ID: 14526933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relative role of plutonium excretion with urine and feces from human body.
    Khokhryakov VF; Suslova KG; Kudryavtseva TI; Schadilov AE; Vostrotin VV; Lagounova NY; Barabanshchikova AY
    Health Phys; 2004 May; 86(5):523-7. PubMed ID: 15083148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. DEVELOPMENT OF CALCULATION TOOL FOR RESPIRATORY TRACT DEPOSITION DEPENDING ON AEROSOLS PARTICLE DISTRIBUTION.
    Iwaoka K; Hosoda M; Tokonami S; Enriquez EB; Palad LJH; Kanda R
    Radiat Prot Dosimetry; 2019 Oct; 184(3-4):388-390. PubMed ID: 31329999
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A computational study of the urinary excretion rates for 339Pu using new ICRP internal dosimetry models.
    Singh IS; Sharma RC; Abani MC
    Radiat Prot Dosimetry; 2003; 105(1-4):361-4. PubMed ID: 14526987
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of plutonium particles in the lungs of Mayak workers.
    Hahn FF; Romanov SA; Guilmette RA; Nifatov AP; Zaytseva YV; Diel JH; Allen SW; Lyovkina YV
    Radiat Prot Dosimetry; 2003; 105(1-4):81-4. PubMed ID: 14526932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influences of parameter uncertainties within the ICRP-66 respiratory tract model: particle clearance.
    Bolch WE; Huston TE; Farfán EB; Vernetson WG; Bolch WE
    Health Phys; 2003 Apr; 84(4):421-35. PubMed ID: 12705441
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adaptation of the ICRP publication 66 respiratory tract model to data on plutonium biokinetics for Mayak workers.
    Khokhryakov VF; Suslova KG; Vostrotin VV; Romanov SA; Eckerman KF; Krahenbuhl MP; Miller SC
    Health Phys; 2005 Feb; 88(2):125-32. PubMed ID: 15650587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhalation deposition and retention patterns of a U-Pu chain aggregate aerosol.
    Briant JK; Sanders CL
    Health Phys; 1987 Oct; 53(4):365-75. PubMed ID: 3654224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Use of air monitoring and experimental aerosol data for intake assessment for Mayak plutonium workers.
    Zaytseva YV; Tretyakov FD; Romanov SA; Miller G; Bertelli L; Guilmette RA
    Radiat Prot Dosimetry; 2007; 127(1-4):535-9. PubMed ID: 17848389
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Practical application of the ICRP Human Respiratory Tract Model.
    Bailey MR; Ansoborlo E; Guilmette RA; Paquet F
    Radiat Prot Dosimetry; 2003; 105(1-4):71-6. PubMed ID: 14526930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo measurement of Pu dissolution parameters of MOX aerosols and related uncertainties in the values of the dose per unit intake.
    Ramounet-Le Gall B; Rateau G; Abram MC; Grillon G; Ansoborlo E; Bérard P; Delforge J; Fritsch P
    Radiat Prot Dosimetry; 2003; 105(1-4):153-6. PubMed ID: 14526947
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Implications of human nasal clearance studies for the interpretation of nose blow and bioassay sample measurements.
    Smith JR
    Radiat Prot Dosimetry; 2003; 105(1-4):119-22. PubMed ID: 14526940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two case studies of highly insoluble plutonium inhalation with implications for bioassay.
    Carbaugh EH; La Bone TR
    Radiat Prot Dosimetry; 2003; 105(1-4):133-8. PubMed ID: 14526943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro dissolution study of plutonium in aerosol particles from the Mayak PA: a tool for individualised dose estimates.
    Aladova EE; Romanov SA; Guilmette RA; Khokhryakov VF; Suslova KG
    Radiat Prot Dosimetry; 2007; 127(1-4):60-3. PubMed ID: 17704503
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of the solubility and size distribution of radioactive aerosols in the uranium processing plant at NRCN.
    Kravchik T; Oved S; Paztal-Levy O; Pelled O; Gonen R; German U; Tshuva A
    Radiat Prot Dosimetry; 2008; 131(4):418-24. PubMed ID: 18676447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The alveloar deposition of inhaled plutonium aerosols in rodents.
    Craig DK; Buschbom RL
    Am Ind Hyg Assoc J; 1975 Mar; 36(3):172-80. PubMed ID: 1146680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.